Targeted Fortification of Human Breast Milk and Adjustment of TPN for Very Low Birth Weight Infants to Optimize Growth and Nutrition Using the Miris Mid-infrared Human Milk Analyzer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Human Milk
- Sponsor
- MetroHealth Medical Center
- Enrollment
- 3
- Locations
- 1
- Primary Endpoint
- Body Composition
- Status
- Terminated
- Last Updated
- 3 years ago
Overview
Brief Summary
This study evaluates the effectiveness of individualized human milk fortification for very low birth weight (<1500 g) babies in the NICU (Neonatal Intensive Care Unit) to optimize their growth. Breast milk analysis will occur on a weekly basis using the Miris Human Milk Analyzer. In the Control group, participants will receive standard TPN (total parenteral nutrition) and lipids and breast milk fortification according to MetroHealth's NICU guidelines. The Intervention group will receive TPN and lipids optimized depending on the results of breast milk analysis, followed by additional individualized fortification using additional microlipids and/or liquid protein to achieve the goal of 4g protein/kg/day and 100-130 kcal/kg/day.
Detailed Description
Human milk has a variety of benefits for neonates, especially premature neonates, including a decreased risk of for necrotizing enterocolitis, sudden infant death syndrome (SIDS), respiratory syncytial virus (RSV) bronchiolitis, respiratory infections, and many other childhood conditions. There is variability in macronutrient and caloric content of breast milk between mothers, making it difficult to accurately quantify the nutritional content the breast milk is providing. The protein content varies by postnatal age, and the fat content varies temporally during a feed. Currently calculations use a standard value for caloric density and macronutrient content of breast milk, which is a reported average, but not necessarily specific to each individual mother. Human milk analysis has been used to address this variability. The Miris Human Milk Analyzer (HMA) is a mid-infrared analyzer and has been evaluated in many studies. It measures the macronutrient content of breast milk, providing values for protein, fat, carbohydrates, and calculated calories. By having this information available, the fortification added to breast milk can be tailored specifically to each mother's breast milk composition to meet each neonate's nutritional needs, and optimize growth.This will be a prospective randomized control study of preterm infants less than 1500 grams \[very low birth weight (VLBW)\] receiving human milk (maternal or donor) will be included. The control group will receive adjustment of total parenteral nutrition (TPN) per NICU guidelines as enteral feedings are advanced followed by standard fortification of human milk. The intervention group will have TPN (protein and lipids) adjusted based on analysis of human milk as feedings are advanced to provide goal 4g/kg/day of protein and 100-130 kcal/kg/day followed by targeted fortification of breast milk based on human milk analysis to continue to provide 4 g/kg/day of protein and 100-130 kcal/kg/day for once full feeds are achieved. The primary aim of this study is to evaluate the growth, anthropometric measurements, and body composition, to see if targeted fortification improves neonatal growth. By optimizing neonatal growth and nutrition there is potential to also have an impact on other morbidities and long term neurodevelopmental outcomes.
Investigators
Sharon Groh-Wargo
Principal Investigator, Neonatal Nutritionist, Clinical Professor
MetroHealth Medical Center
Eligibility Criteria
Inclusion Criteria
- •Premature infants \<1500 g
- •Mother consenting to provide breast milk or use of donor breast milk
Exclusion Criteria
- •Infants with major congenital malformations
- •Infants with medical conditions precluding them from having breast milk
- •Mothers with medical conditions that preclude them form providing breast milk
- •Insufficient breast milk supply
- •Refusal of donor breast milk
- •Mother is non-English speaking
Outcomes
Primary Outcomes
Body Composition
Time Frame: 4 weeks after baby reaches full feeds (150 mL/kg/day) or at NICU discharge
Body composition will be measured by air displacement plethysmography (PEAPod). As standardized assessment of body composition is relatively new in the preterm infant population, we are using clinical judgment to determine that a difference in fat free mass z-score (from data from Norris T, 2019) of 0.5 is clinically significant.
Secondary Outcomes
- Weight Gain Velocity(From enrollment in study to 4 weeks after full feeds (150 mL/kg/day) or at NICU discharge.)
- Body Composition(From enrollment in study to 4 weeks at full feeds (150 mL/kg/day) or at NICU discharge.)
- Linear Growth(From enrollment in study to 4 weeks at full feeds (150 mL/kg/day) or at NICU discharge.)
- Weight Gain(From enrollment in study to 4 weeks at full feeds (150 mL/kg/day) or at NICU discharge.)
- Head Circumference Growth(From enrollment in study to 4 weeks at full feeds (150 mL/kg/day) or at NICU discharge.)